
Twelve years of multiples investors have paid for Banka BioLoo Limited, framed against the sector median so the premium or discount is obvious at a glance.
Auto-detected classical chart patterns for Banka BioLoo Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Twelve years of audited numbers for Banka BioLoo Limited, switchable between annual and quarterly views, consolidated or standalone.
Banka BioLoo Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹96.99 Cr and reported EPS of ₹-3.83.
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 30 | 39 | 42 | 50 | 54 | 57 |
| Other Income | 1 | 0 | 1 | 0 | 0 | 1 |
| Total Income | 31 | 39 | 43 | 50 | 55 | 58 |
| Cost of Goods Sold (COGS) | 4 | 7 | 6 | 16 | 16 | 14 |
| Gross Profit | 27 | 32 | 37 | 34 | 38 | 43 |
| +Operating Expenses | 23 | 27 | 31 | 30 | 41 | 38 |
| EBITDA | 3 | 6 | 6 | 4 | -3 | 5 |
| +Non-Operating Expenses | 2 | 3 | 3 | 5 | 6 | 6 |
| Profit Before Tax (PBT) | 2 | 3 | 4 | -1 | -9 | -0 |
| +Tax Expense | -0 | 0 | 1 | 0 | -0 | -1 |
| Total Profit for Period | 2 | 3 | 3 | -1 | -9 | 0 |
| Less: Non-controlling Interests | — | — | — | -0 | — | 0 |
| Net Profit (Owner's PAT) | 2 | 3 | 3 | -1 | -9 | 0 |
| Earnings Per Share (EPS) | 2.14 | 3.02 | 2.34 | -0.46 | -8.19 | 0.32 |
| Diluted Shares Outstanding (Nos.) | 1 | 1 | 1 | 1 | 1 | 1 |
| +Additional Disclosures | 33 | 43 | 45 | 67 | 80 | 73 |
| Sales Growth % | — | 27.23 | 9.29 | 18.06 | 8.36 | 5.39 |
| YoY Sales Growth % | — | 27.23 | 9.29 | 18.06 | 8.36 | 5.39 |
| Material Cost % | 23 | 20 | 14 | 22 | 29 | 24 |
| Employee Cost % | 43 | 46 | 56 | 48 | 54 | 49 |
| Other Cost % | 34 | 23 | 17 | 12 | 22 | 18 |
| OPM % | 11 | 14 | 14 | 7 | -5 | 9 |
| Tax % | -18 | 6 | 30 | -20 | 2 | 224 |
| Profit Growth % | — | 40.94 | -18.30 | -125.70 | -1,265.30 | 103.94 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| +Additional Fields | 3 | 5 | 4 | 1 | -5 | 2 |
Disclosed business segments at Banka BioLoo with their share of revenue and profit, switchable between consolidated and standalone reporting.
Banka BioLoo discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Banka BioLoo Limited, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Banka BioLoo Limited's investment case rests on 7 positive markers and 10 flagged concerns drawn from the latest reported filings.
Substantial promoter holding (52.4%) indicates strong insider confidence and control.
Specialization in environmental sanitation solutions aligns with sustainable infrastructure demand.
Involvement with Indian Railways showcases capacity for substantial contracts.
Civil Construction sector growth, government spending, urbanization offer market expansion.
Growing demand for sustainable infrastructure and government initiatives like Swachh Bharat.
Severely negative ROE (-23.64%) and ROCE (-7.61%) indicate operational inefficiencies.
High debt-to-equity ratio (1.10) and negative OPM (-13.63%) raise solvency concerns.
Recent quarterly sales (-13.60%) and profit (-96.60%) show significant deterioration.
Persistent negative EPS (-8.48) reflects ongoing losses and poor shareholder returns.
Absence of FII/DII holdings (0.00%) limits liquidity and market confidence.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.42. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Banka BioLoo Limited is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Banka BioLoo Limited — derived from the live tape, not yesterday's close.
Banka BioLoo Limited last traded at ₹74.18 with an intraday range of ₹72.38–₹79.98 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 93.85 | +19.67 | +26.51% |
| R3 | 86.25 | +12.07 | +16.27% |
| R2 | 83.11 | +8.93 | +12.04% |
| R1 | 78.65 | +4.47 | +6.02% |
| PIVOT | 75.51 | 1.33 | 1.80% |
| CURRENT | 74.18 | — | — |
| S1 | 55.85 | -18.33 | -24.71% |
| S2 | 63.45 | -10.73 | -14.47% |
| S3 | 67.91 | -6.27 | -8.45% |
| S4 | 71.05 | -3.13 | -4.22% |
BANKA is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ~
Trading Inside opening range
Daily traded volume and delivery percentage for Banka BioLoo Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Banka BioLoo Limited stood at 72.0% of traded volume, against a 20-day average of 79.5%.
Filings Banka BioLoo sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Banka BioLoo files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 59 documents below.
Banka BioLoo Limited has informed the Exchange of the submission of Audited Standalone and Consolidated Financial Results for the quarter and year…
Banka BioLoo Limited has informed the Exchange regarding the allotment of 9500 equity shares under the Banka BioLoo Limited Employee Stock Option…
Banka BioLoo Limited has informed the Exchange about Copy of Newspaper Publication
Banka BioLoo Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Every dividend, stock split and bonus issue Banka BioLoo has declared, sequenced by announce and record date.
Banka BioLoo corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Banka BioLoo Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Banka BioLoo Limited operates in the Commercial Services & Supplies industry under the Construction sector, listed as NSE: BANKA.

Banka BioLoo Limited is an Indian sanitation and wastewater treatment company established in 2012 and headquartered in Hyderabad. Their core business revolves around the design, installation, operation, and maintenance of various wastewater and fecal sludge treatment systems. This includes a wide range of solutions tailored for diverse clients and applications.
A significant part of Banka BioLoo's operations focuses on the development and deployment of its proprietary sanitation technologies. These include the BioToilet, BioDigester, and FootLoo systems, which are designed to address sanitation challenges efficiently and sustainably. The company also offers packaged and urban sewage treatment plants, catering to a broader range of needs, from individual households to large-scale municipal projects.
Beyond individual and community-based solutions, Banka BioLoo extends its services to industrial and commercial sectors. Their expertise is leveraged by various businesses to manage their wastewater effectively and comply with environmental regulations. A notable example of their large-scale projects is their involvement in the installation and maintenance of bio-toilets for Indian Railways, showcasing their capacity to handle substantial contracts.
The company’s commitment to sustainability is further highlighted by its production of granules and biopellets for compostable packaging. This demonstrates a broader engagement in waste management and the circular economy, reducing reliance on non-biodegradable materials. In essence, Banka BioLoo offers a comprehensive suite of services covering the entire spectrum of sanitation and wastewater treatment, contributing significantly to improved hygiene and environmental protection in India.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Banka BioLoo Limited (BANKA) is ₹74.18. Today, the stock has declined by ₹2.00 (2.63%), trading in a range of ₹72.38 to ₹79.98. The stock opened at ₹77.8 with a trading volume of 41,011 shares.
The 52-week high price of Banka BioLoo Limited (BANKA) is ₹97.88, while the 52-week low is ₹41. Currently trading at ₹74.18, the stock is 58.3% away from its 52-week low and 24.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Banka BioLoo Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹74.18, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Banka BioLoo Limited stock opened at ₹77.8 and is currently trading at ₹74.18, showing a decline of ₹2.00 (2.63%). The intraday high is ₹79.98 and low is ₹72.38. The trading volume stands at 41,011 shares, indicating moderate market participation today.
Banka BioLoo Limited has a market capitalization of ₹96.99 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹74.18) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Banka BioLoo Limited has a book value of ₹28.98 per share and a Price-to-Book (P/B) ratio of 3.00. The current market price is ₹74.18, which is 156.0% above the book value. A P/B ratio above 1 indicates the stock trades above its book value.
Banka BioLoo Limited has a Return on Equity (ROE) of 0.92% and Return on Capital Employed (ROCE) of -7.61%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Banka BioLoo Limited operates in the Construction sector and belongs to the Civil Construction industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
The data, ratios and commentary about Banka BioLoo Limited (BANKA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.